Cargando…
Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine
Nanoparticle-based anticancer medications were first approved for cancer treatment almost 2 decades ago. Patients benefit from these approaches because of the targeted-drug delivery and reduced toxicity, however, like other therapies, adverse reactions often limit their use. These reactions are link...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819852/ https://www.ncbi.nlm.nih.gov/pubmed/33488603 http://dx.doi.org/10.3389/fimmu.2020.603039 |